// REFERENCE / concepts
A 27-entry glossary for Blueprint, Don't Die, biomarker protocols, Female-specific Blueprint, source-aware critiques, and tweet-backed concepts that do not yet have dedicated wiki pages.
Source-aware summaries only; not medical advice. Confidence labels describe public-dashboard certainty, not clinical truth.
Johnson says an endo-specific ultrasound, AI-assisted pelvic MRI, and microRNA/protein blood test converged on a non-surgical endometriosis diagnosis; useful as a multi-modality measurement case study, not medical advice or cure evidence.
raw/articles/bryan-johnson/x-twitter-daily-2026-07-10.md Johnson proposed a staged AIG cure attempt using live T-cell matching, biweekly blood/wearable monitoring, cryopreserved immune cells, and ex-vivo therapy tests; roadmap evidence, not an approved cure.
raw/articles/bryan-johnson/x-twitter-daily-2026-07-09.md Johnson recast his AIG story as an 11-year low-ferritin diagnostic miss and reported Monoferric ferritin follow-up; useful as measurement ethos, not iron-treatment advice.
raw/articles/bryan-johnson/x-twitter-daily-2026-07-08.md Johnson says he is sequencing 1M immune cells to identify autoreactive clones behind autoimmune gastritis; a cellular/receptor-level measurement layer, not a proven therapy or reader recommendation.
raw/articles/bryan-johnson/x-twitter-daily-2026-07-04.md Johnson reported a negative 71-gene Invitae inherited-cancer panel with DNA plus RNA analysis; useful as a risk-stratification measurement signal, not clinical screening advice.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-26.md Johnson’s June 24 essay defines immortality as life expectancy gains outpacing aging and introduces the Die Economy vs Don’t Die Economy frame; important ideology, not validation of the 2039 forecast.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-25.md Johnson argues divergent wearable numbers can still be useful for within-device trend tracking; this supports longitudinal measurement while leaving accuracy questions open.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-25.md Johnson’s June 23 essay frames blood draws, wearables, and imaging as chemical/functional/structural measurement layers; useful methodology signal, not proof the device improves outcomes.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-24.md Johnson suggests at most one international trip per quarter based on his travel biomarker recovery; N=1 behavioral prescription, not clinical guidance.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-24.md Johnson announced semaglutide/Wegovy, tirzepatide/Zepbound, SGLT2 inhibitors, peptide complexes, glutathione, and NAD+ as part of a wider Immortals Rx catalog; commercial platform news, not medication advice.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-23.md Johnson explicitly says the company has changed its name to Immortals; notable as movement/brand positioning, not a medical claim.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-20.md A June 2026 N=1 skin-aging metric claim after Australia travel; useful as protocol readout context, not independent validation.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-20.md The measurement-led routine and intervention stack Johnson presents as Blueprint.
concepts/blueprint-protocol.md A June 2026 microbiome supplement launch; notable as product expansion, not clinical validation.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-19.md Johnson’s N=1 circadian recovery claim using glucose as readout after Australia travel.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-19.md The feedback-loop idea that biomarkers guide protocol changes, with caveats about outcomes.
concepts/biomarker-driven-longevity-protocols.md A June 2026 N=1 test using ingestible temperature tracking and blood biomarkers; useful as protocol design, not medical advice.
raw/articles/bryan-johnson/x-twitter-daily-2026-06-17.md Delegating health decisions to measurement, rules, and repeatable systems.
concepts/algorithmic-health.md Johnson’s anti-death ideology and movement framing.
concepts/dont-die.md An aspirational longevity claim that should stay clearly low-confidence.
concepts/immortality-by-2039.md The company/protocol ecosystem around Johnson’s routine, products, and measurement claims.
entities/project-blueprint.md The public brand/entity layer for products, protocol content, and community positioning.
entities/blueprint.md A cycle-aware baseline project; source-aware because no dedicated synthesized wiki page exists yet.
queries/bryan-johnson-recent-news-changelog.md + raw X/Kate articles Johnson’s enhancement-competition framing, not independent safety validation.
raw/articles/bryan-johnson/x-twitter-daily-2026-05-25.md The principle that a protocol can reverse or pause interventions when measurements or risk assessments change.
raw/articles/bryan-johnson-x-paused-metformin-2025-08-07.md The critique that biomarker improvements do not automatically prove better long-term outcomes.
raw/articles/bryan-johnson/years-biomarkers-limits-2026-04-20.md The broader ideology tying health, survival, AI-era alignment, and anti-entropic framing together.
raw/articles/bryan-johnson-x-targeted-searches-2026-05-22.md